Date published: 2026-5-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

CGP 39551 (CAS 127910-32-1)

0.0(0)
Write a reviewAsk a question

Application:
CGP 39551 is a potent, selective and competitive NMDA antagonist
CAS Number:
127910-32-1
Molecular Weight:
237.19
Molecular Formula:
C8H16NO5P
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

CGP 39551 is a potent, selective, and competitive NMDA antagonist.


CGP 39551 (CAS 127910-32-1) References

  1. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.  |  D'Hooge, R., et al. 1999. Fundam Clin Pharmacol. 13: 67-74. PMID: 10027090
  2. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test.  |  Maj, J., et al. 1992. Pol J Pharmacol Pharm. 44: 337-46. PMID: 1363131
  3. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.  |  Löscher, W. and Hönack, D. 1991. J Pharmacol Exp Ther. 256: 432-40. PMID: 1671593
  4. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.  |  Chapman, AG., et al. 1991. Epilepsia. 32: 578-87. PMID: 1678345
  5. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.  |  Fagg, GE., et al. 1990. Br J Pharmacol. 99: 791-7. PMID: 1972895
  6. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.  |  Schmutz, M., et al. 1990. Naunyn Schmiedebergs Arch Pharmacol. 342: 61-6. PMID: 1976233
  7. CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.  |  Fagg, GE., et al. 1990. Prog Clin Biol Res. 361: 421-7. PMID: 1981260
  8. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.  |  Maj, J., et al. 1993. Pol J Pharmacol. 45: 349-60. PMID: 7906989
  9. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.  |  Czechowska, G., et al. 1993. Eur J Pharmacol. 232: 59-64. PMID: 8096188
  10. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.  |  Maj, J., et al. 1993. J Neural Transm Park Dis Dement Sect. 6: 53-62. PMID: 8105798

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

CGP 39551, 10 mg

sc-361139
10 mg
$159.00

CGP 39551, 50 mg

sc-361139A
50 mg
$645.00